Therefore, a meta‐analysis of available evidence on CSF and blood levels of NFL was performed in patients with ALS and with FTD and related entities (bvFTD and FTLDSs) compared to healthy controls and patients with other neurological diseases. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.